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Oxidative Metabolism of 4-Aminobutyrate by Rat Brain
Mitochondria: Inhibition by Branched-chain Fatty Acid
J. Cunningham, D. D. Clarke, and W. J. Nicklas*

Abstract: The oxidation of 4-aminobutyric acid (GABA) by nonsynaptosomal
mitochondria isolated from rat forebrain and the inhibition of this metabolism
by the branched-chain fatty acids 2-methyJ-2-ethyl caproate (MEC) and 2,2dimethyl valerate (DMV) were studied. 1·ne rate of GABA oxidation, a s measured by 0 2 uptake, was determined in medium containing either 5 or 100
mM-[K+]. The apparent K 111 for GABA was 1.16 ± 0.19 mM and the V max in
state 3 was 23.8 + 5.5 ng-atoms 0 2 ·min- I. mg protein- 1 in 5 mM-[K +]. In a
medium with 100 mM-[K+] the apparent K 111 was 1.11 + 0.17 mM and V max was
47.4 + 5. 7 ng-atoms 0 2 · min- 1. mg protein- 1 • The K; for MEC was determined
to be 0.58 + 0.24 or 0.32 + 0.08 mM, in 5 or 100 mM-[K+J, respectively. For
DMV, the K; was 0.28 + 0.05 or 0.34 + 0.06 mM, in 5 or 100 mM-[K+] medium,
respectively. The 0 2 uptake of the mitochondria in the presence of GABA was
coupled to the formation of glutamate and aspartate ; the ratio of oxygen uptake
to the rate, of amino acid formation was close to the theoretical value of 3.
Neither the [K+] nor any of the above inhibitors had any effect on this ratio.
The metabolism of exogenous succinic semialdehyde (SSA) by these same
mitochondria was also examined. The V max for utilization of oxygen in the
presence of SSA was much greater than that found with exogenously added
GABA , indicating that the capacity for GABA oxidation by these mitochondria
is not limited by SSA dehydrogenase . In addition, the branched-chain fatty
acids did not inhibit the metabolism of exogenously added SSA. Thus , the
inhibitors examined apparently act by competitively inhibiting the GABA
transaminase system of the mitochondria. Key words: 4-Arninobutyrate
(GABA)-Brain mitochondria-2-Methyl-2-ethylcaproic acid-2 ,2-Dimethylvalerie acid-Succinic semialdehyde.

4-Aminobutyric acid (GABA) is a putative inhibitory neurotransmitter in the mammalian CNS. Its
inhibitory activity is believed to be terminated by
diffusion away from the synaptic cleft and subsequent active transport into surrounding structures
where it is metabolized via GABA transaminase
(GABA- T) [ 4-aminobutyrate: 2-oxoglutarate
aminotransferase, EC 2.6.1.19] (Roberts and
Kuriyama, 1968). It has been proposed (Balazs et
al. , 1973) that the metabolism of GABA is compartmentalized in the brain; i.e., its synthesis oc-

curs in the presynaptic terminal and its degradation
occurs in the cells that take up GABA from the
synapse.
Pharmacological manipulations that decrease
GABA levels in the brain are often associated with
seizure activity (Wood and Peesker, 1974). Conversely, increasing GABA levels by inhibiting its
catabolism can protect against the onset of convulsions. Recently, a class of small, branched-chain
fatty acids have been shown to inhibit GABA
metabolism in vivo and in vitro and to have an-
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tiepileptic properties (Simler et al. , 1968, 1973; Lespagnol et al. , 1972). Some controversy exists as to
the mechanism by which these substances act (Harvey et al., 1975). In particular, it is debated whether
GABA-T or succinic-semialdehyde dehydrogenase
(SSADH) [succinic-semialdehyde: N AD(P)+ oxidoreductase (EC 1.2. L 16)] is the enzyme inhibited .
This study focuses on the oxidative metabolism
of GABA by non - synaptic-ending brain mitochondria (Clark and Nicklas , 1970; Walsh and Clark,
1976) and the effect thereon of two such inhibitors ,
2-methyl-2-ethyl caproic acid (MEC) and 2,2dimethyl valerie acid (DMV) . These substances
were found to be potent inhibitors of GABA oxidation and appeared to act solely on the transamination reaction.
METHODS

Preparation of Rat Brain Mitochondria
Rat brain mitochondria were prepared essentially according to the method of Clark and Nicklas (1970). The
final mitochondrial pellet was suspended in ice-cold buffer consisting of 0.32 M-sucrose , 0.1 mM-EDTA , and 10
mM-Tris - HCl , pH 7.4, to give a final protein concentration of 15 mg/ml. Generally , the yield from eight rats was
18-22 mg mitochondrial protein as determined by the
method of Lowry et aJ. (1951 ), with bovine serum albumin
as the standard. Mitochondria prepared in this manner are
primarily of non -synaptic-ending origin (Clark and
Nicklas, 1970; Walsh and Clark, 1976).

Incubation Conditions
To study the respiration and respiratory control of a
given mitochondrial preparation, an aliquot of the suspension described above (0. 5- 0.75 mg protein) was
pipetted into a final volume of 1 ml incubation medium at
either 28°C or 33°C in a chamber with a 2-ml volume. The
basic incubation medium consisted of the following: 5
mM-K+ medium-225 mM-mannitol, 75 mM-sucrose , 5
mM-phosphate, 0.05 mM-EDTA , 5 mM-KCl, adjusted to
pH 7.4; 100 mM-K+ medium-75 mM-mannitol, 27 mMsucrose, 5 roM-phosphate , 0.05 mM-EDTA, 100 mM-KCl ,
adjusted to pH 7.4 with I M-Tris. Then , 0.05 mM-pyruvate
and 2.5 mM-malate were added and state 3 oxidation was
initiated by addition of 0.5 mM-ADP. Oxygen uptake was
followed utilizing a Clark-type electrode (Yellow Springs
Instrument Co.). The oxygen uptake in ng-atoms of oxygen· min- 1 · mg protein- 1 under the above conditions was
similar to that reported in earlier studies (Clark and
Nicklas , 1970) and the respiratory control (Chance arid
Williams, 1956) for 5 mM or 100 mM-K+ media was 9-12
or 8- 11 , respectively , at 28°, and 4 - 5.5 and 3.5- 5, respectively, at 33°. Greater respiratory control ratios were
obtained at the elevated temperature if 1 mg/ml bovine
serum albumin was added but, since this interfered with
the later, inhibitory studies, no albumin was used in these
experiments.
To study oxygen consumption with GABA as substrate, the protein concentration in the incubation solution was doubled . AU studies were carried out at 33°C. As
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described in Results , a small amount of 2-oxoglutarate
was necessary to optimize initial rates of oxygen utilization. Arsenite was added to inhibit direct oxidation of the
added 2-oxoglutarate. For determination of the Km of
GABA oxidation, the media used consisted of the basic 5
mM- or 100 mM-K+ media described above plus 0.25
mM-malate, 0.05 mM-2-oxoglutarate, 1 mM-ADP, and 0.5
mM-arsenite. The concentration of GABA was varied
from 0.025 rnM to 5 mM , the GABA being added last.
Inhibitory studies were carried out in the same mitochondrial incubation media as those described above. The
concentration of GABA was kept constant at either 2.5
mM or 10.0 mM and the inhibitor, either MEC or DMV,
was varied in concentration from 0 to 2.5 mM. The inhibitor was added to the mitochondrial preparation just prior
to the addition of GABA.
In some cases , samples of the incubation mixtures were
assayed for glutamate and aspartate content. After
monitoring the 0 2 uptake for 3 min after addition of
GABA, both in the presence and absence of inhibitors, 1
ml of the total mixture was mixed with 0.04 ml 70% perchloric acid (PCA). Glutamate and aspartate in the PCA
extract were determined either by enzymatic fluorometric
procedures (Williamson and Corkey , 1969) or with a
Technicon Autoanalyzer (Nicklas and Browning, 1978).
Comparable results were obtained with either method.

Kinetic Parameters
The kinetic parameters of GABA catabolism were determined by regression analysis of an S/V versus S plot
using the internal program of the Hewlett Packard 9805A
Statistic Calculator. The S/V versus S plot was chosen
because of its more even weighing of the points throughout the substrate concentration range (Wilkinson , 1961).
The kinetics in the presence of the inhibitors were
evaluated using regression analyses on Dixon plots
(Dixon , 1953).

Chemicals
All reagent chemicals were of the highest purity commercially available. Ficoll, malate, aminooxyacetic acid,
and GABA were obtained from Sigma Chemical Co. , St.
Louis, Missouri. Pyridine, 2-oxoglutarate, and adenine
nucleotides , as well as the enzymes used in the fluorometric assays , were obtained from Boehringer Mannheim
Biochemicals, Indianapolis, Indiana. Pyruvic acid (Calbiochem) was redistilled under vacuum and stored at
2- SOC. Sodium arsenite was a product of Fisher Scientific Company, Fair Lawn , New Jersey. 2-Methyl-2-ethyl
caproic and 2,2-dimethyl valerie acids were from ICN
Pharmaceuticals Inc., Plainview, New York. Their purity
was checked by nuclear magnetic resonance spectrometry. Working solutions of these acids were neutralized with Tris (pH 7. 0) prior to addition to incubation
mixtures.

RESULTS
Oxidation of GABA by Brain Mitochondria

Addition of GABA to mitochondrial preparations
caused an increase in state-3 oxygen uptake which

MITOCHONDRIAL OXIDATION OF GABA
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FIG. 1. Oxygen uptake by rat brain mitochondria with GABA as substrate. Mitochondria (1.8 mg protein) were placed in 1 ml of
incubation medium at 33°C. (A) GABA oxidation in the absence of inhibitor and (B) GABA oxidation in the presence of methyl
ethyl caproate (MEC). Initially, the med.ium contained 5 mM-[K +] incubation medium (see Methods), 0.5 mM-sodium arsenite, 50
JJ-M 2-oxoglutarate, and 0.25 mM-malate. Adenosine diphosphate (ADP), GABA, aminoxyacetate (AOAA), and succinate were
added where indicated by the arrows. Oxygen consumption is in the downward direction. The numbers above each line segment
represent the oxygen utilization in ng-atoms · min - 1 • mg protein- 1 •

was measurable, but small, in comparison to pyruvate or succinate oxidation. The procedure finally
adopted is i11ustrated in Fig. 1 and gives reproducible GABA oxidation rates for kinetic studies.
Similar to findings of Walsh and Clark (1976) in their
studies of GABA transamination in intact
mitochondria, it was necessary to add 2oxoglutarate to the medium for optimal GABA utilization. The apparent Ka for 2-oxoglutarate for this
effect was approximately 10 p.M; 50 p.M- 2oxoglutarate was added in the kinetic studies to give
maximal activation. This concentration of 2oxoglutarate is one-fiftieth that used by Walsh and
Clark (1976) and is much less than the concentration
that has been shown to cause substrate inhibition of
GABA-T (Maitre et al., 1975).

It was also necessary to add malate (0.25 mM) to
the system, probably to maximize 2-oxoglutarate
transport into the mitochondria. Aminooxyacetic
acid at 1 mM added to the system resulted in a 95%
inhibition of the respiration rate under these conditions. When 10 mM-succinate was added, an immediate increase in oxidation to 160-180 ng-atoms
oxygen · min- 1 · mg protein- 1 resulted, comparable to succinate oxidation found in intact, uninhibited mitochondria. Increasing the [K+] (Table 1) in
the medium from 5 to 100 mM altered the kinetics of
GABA oxidation. The Km for GABA metabolism as
measured by 0 2 uptake was similar in both incubation media, but there was a doubling in v max for
GABA oxidation in going from 5 to 100 mM K +
medium (Table 1).

TABLE 1. Kin etic parameters (Km, Vma.r• KJ for GABA oxidation and
its inhibition by DMV and MEC in rat brain mitochondria
Incubation Medium
100 mM-[K+]

Parameter, species

Km. GABA (mM)
Vma x, GABA (ng-atoms 0 2/minlmg protein)
K 0 , 2-oxoglutarate (~M)
Km, succinic semialdehyde (mM)
v max ' succinic semialdehyde
(ng-atoms 0 2/rnin/mg protein)
Kt, MEC (mM)
Kt, DMV (mM)

1.16 + 0.19
23.8 ± 5.5
8.6 ± 0.5
0.13 ± 0.02
52.9 ± 6.6

0.10 ± 0.01
66.7 ± 5.5

0.58 + 0.24
0.28 ± 0.05

0.32 ± 0.08
0.34 ± 0.06

1.11±0.17
47.4 + 5.7

Km and Vmax were obtained by extrapolation of S/V vs. S plots. K1' s for inhibitors of
GABA oxidation were determined by extrapolation of Dixon plots for two concentrations of GABA, 2.5 mM and 100 mM.
All parameters are mean values from three experiments + s. o.
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The oxidation of GABA requires the enzymes
GABA-T and SSADH. To determine whether the
activity of the mitochondrial SSADH was sufficient
for oxidation of SSA produced by the GABA-T
under these conditions , the rate of oxidation for exogenous succinic semialdehyde (SSA) was determined. The Km for exogenous SSA oxidation was
found to be an order of magnitude less than that for
GABA (Table 1). The Vm ax for exogenous SSA oxidation was 100% greater than that of GABA in 5 mM
K+ incubation medium and 50% greater in 100 mM
K+ medium. The oxidation of SSA was completely
inhibited by rotenone (0.2 mM).
Effect of MEC and DMV on GABA and SSA
Oxidation
Both MEC and DMV inhibited GABA-supported
respiration by the brain mitochondria (Tables 1, 2,
Fig. 2). Dixon plots indicated that the inhibition, in
both cases, was competitive with exogenous GABA
(illustrated for inhibition by DMV in Fig. 2). There
was no substantial difference in the inhibitory kinetics between 5- and 100-mM [K+] medium (Table
1, Fig. 2). Similar kinetic changes were obtained
when the inhibitor was added before or after the
GABA. In the results reported here, the inhibitors
were added before GABA. The Km of SSA as well
as the Vmax of its oxidation were unaffected by concentrations of DMV and MEC up to 1.0 mM.
Comparison of Oxygen Utilization with
Production of Glutamate and Aspartate
A comparison was made of oxygen utilization to
the amount of glutamate plus aspartate produced
during GABA oxidation (Table 2). The ratio of oxygen utilization (ng-atoms 0 2 · min- 1 · • mg protein- 1)
to amino nitrogen transfer (nmol [glutamate + aspartate] · min- 1 · mg protein- 1) from GABA to

glutamate and then via further transamination to aspartate was 3.35 + 0.34. This value was slightly
greater than the theoretical value of 3 for flow of
carbon from GABA to oxa1oacetate via GABA-T,
SSADH, and the tricarboxylate cycle. Alteration in
the [K+] had no effect on this ratio. The rate of
glutamate plus aspartate production during GABA
oxidation was inhibited by MEC and DMV and the
percentage inhibition was similar to the percentage
inhibition of 0 2 uptake. MEC or DMV (0.25 mM)
inhibited 0 2 uptake and amino acid production by
about 50% in both 5 mM- and 100 mM-K+ media.
DISCUSSION
The metabolism of GABA by intact brain
mitochondria is subject to regulation at several
levels. The first is at the point at which it is transported across the mitochondrial inner membrane.
Previous studies (Brand and Chappel, 1974; Walsh
and Clark, 1976) have shown this transport to occur
by passive diffusion. Therefore , the rate of GABA
oxidation must be regulated at the level of GABA
catabolism, i.e., GABA-T, SSADH, and the enzymes of the tricarboxylate cycle. As has been discussed by Walsh and Clark (1976) , studies ofGABA
metabolism in mitochondrial preparations have
been confusing, especially with regard to the extent
to which GABA can serve as a substrate for mitochondrial respiration . The above investigators
showed various kinetic and regulatory differences
in GABA metabolism in " synaptic" versus "free"
brain mitochondria. Several of the conclusions of
that study are corroborated by the data presented
here. However, there are several points of divergence worth noting.
Whereas Walsh and Clark ( 1976) used measurements of glutamate production as a measure of
GABA oxidation, we have used both oxygen utilization and the rate of formation of the sum of

TABLE 2. GABA metabolism by rat brain mitochondria: Comparison of oxygen
utilization vs . glutamate - aspartate production

[K +]

0 2 uptake

(Glu + Asp)

% GABA
oxidation,
0 2 uptake

A
B

23.1 ± 2.8
46.4 ± 3.6

7.1 + 0.8
13.4 ± 1.6

100
100

100

2.5 mM-GABA
+ 0.25 mM-MEC

A
B

11.7 + 2.0
17.1 ± 1.9

3.2 + 0.1
5.6 ± 0.3

50 ± 2
48 + 4

45 ± 4
42 + 3

2.5 mM-GABA
+ 0.25 mM-DMV

A
B

9.4 ± 1.0
21.4 + 2.3

2.8 ± 0.3
5.7 ± 0.5

41 ± 4
54 + 4

39 + 5
43 ± 5

2.5

mM

GABA

% GABA
oxidation
(Gla + Asp)
100

Mitochondria were incubated in either 5 mM- (A) or 100 mM-[K +] (B) medium with GABA or
GABA + inhibitor. The oxygen uptake was measured for 3 min, at which point the reaction was terminated with PCA. The results are averaged from three different preparations + s. o. 0 2 uptake is
measured in ng-atoms · min- 1 • mg protein- 1 •
(Glu + Asp) is the increase in glutamate and aspartate over the concentration of these amino acids in
the absence of GABA. The units of this quantity are nmole · min-t · mg protein- 1 •
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FIG. 2. Dixon plots of inhibition by dimethylvalerate (DMV) on GABA oxidation by rat brain mitochondria. Mitochondria were
incubated in state 3 at 33° with either 10 mM-GABA (A) or 2.5 mM-GABA (8), and various concentrations of DMV and the rate of
oxygen uptake, V (ng-atoms 0 2 · min- 1 · mg protein - 1), were measured . The kinetics are illustrated for results obtained with
either 5 mM- (left) or 100 mM-[K+] (right) incubation medium . Each point is the average of three different preparat ions ± s.o.

glutamate plus aspartate. Since varying the rate of
oxygen utilization (either by using inhibitors or by
changing [K+J) did not alter the ratio of oxygen uptake to formation of dicarboxylic amino acids, measurement of either parameter is apparently a valid
indicator of oxidative GABA metabolism. It is interesting to note that there was a doubling in state-3
GABA oxidation in going from 5 to 100 mM-[K+]; no
such increase was seen by Walsh and Clark (1976)
in their studies. Stimulation of brain mitochondrial
respiration by K+ has been reported by several authors (see Nicklas et al., 1971). In the present
studies, the mitochondrial transaminases were
coupled; i.e. , amino groups from GABA were
transferred to 2-oxoglutarate via GABA-T and then
on to oxaloacetate via aspartate aminotransferase.
Perhaps, the intactness of this system allowed the
K+-enhanced oxidation and transamination to
occur.
Walsh and Clark (1976) suggested that mitochondrial aspartate aminotransferase was inhibited by
the relatively high concentration of 2-oxoglutarate
(2.5 mM) used in their experiments. Others (Maitre
et al., 1975; van der Laan et al., 1979) have shown
that 2-oxoglutarate can exert a substrate inhibition
on GABA-T activity in vitro , with an estimated Ki
of about 3 mM. The coupling of GABA oxidation
and concomitant ' irreversible' ' formation of dicarboxylic amino acids is consis~ent with proposed
models of brain amino acid metabolism (van den
Berg and Garfinkel, 1971). The maximal flux of the
" GABA shunt" in these experiments was 8- 11% of
the pyruvate utilization by these mitochondria,
which is also in agreement with calculations on the
4

in vivo and in vitro GABA flux relative to total
tricarboxylate cycle flux in brain (Balazs et al. ,
1973).
Dysfunctions in GABAergic systems have been
postulated to play a role in several disorders, e.g. ,
epilepsy (van Gelder et al. , 1972), Huntington' s
chorea (Perry et al. , 1973 ; Bird and Iversen , 1974;
Enna et al., 1976), meningitis (Burkakova et al.,
1975), cerebrovascular disease (Achar et al. , 1976),
and psychiatric illness (Roberts, 1972, 1976; Langer
et al. , 1975). ExperimentalJy , elevating brain GABA
levels has been shown to be especially useful in
protecting against convulsions (Simler et al., 1968).
No method has yet been devised to increase GABA
levels by stimulating synthesis per se. However,
inhibiting GABA catabolism has been successful.
Specifically , several branched-chain fatty acids
have been shown to protect against seizures (Simler
et al. , 1968, 1973; Lespangnol et al., 1972). One of
these , sodium n-dipropyl acetate (DPA) has been
introduced as a clinical anticonvulsant (Jeavons
and Clarke, 1974). This substance produces a rise
in total brain GABA, which has been suggested to
occur by inhibition of either GABA-T (Simler et al. ,
1973) or, more likely , SSADH (Harvey et al. , 1975;
van der Laan et al., 1979). In preliminary experiments with brain mitochondria, DPA had no appreciable effect on GABA catabolism at levels
similar to those used for MEC and DMV; concentrations of DPA that inhibit GABA-T (K1 = 18 mM,
Maitre et al. , 1974) uncoupled brain mitochondrial
respiration (Dziedzic and Nicklas , unpublished
observations). However, the two analogues of
DPA used in the present studies were found to be
J . Neurochern., Vol. 34 , No. / , 1980
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potent competitive inhibitors of GABA oxidation in
intact mitochondria. Maitre et al. ( 1974) found that
these substances, which protect against seizures
induced audiogenically (Maitre et al., 1974) or by
electric shock, pentetrazol, or strychnine administration (Lespagnol et al., 1972), were more potent
GABA-T inhibitors than was DPA.
The results of these experiments indicate that the
study of the oxidation of GABA by an intact mitochondrial preparation is a useful means of assessing
various parameters of GABA metabolism. As such
it can bridge the gap between studies in vivo, in
which results are often difficult to interpret, and
those with enzyme preparations, whose applicability to the intact state is often questioned.
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